Resources for Healthcare Professionals
The MCPHD offers a free asthma referral service
Environmental assessment of the home, schools, workplace
Public Health Nurse
Dietician covering Kids Medicaid/Hoosier Healthwise assistance
Education offered for topics such as:
|Marion County Public Health Department|
Asthma - Best Practices Guidelines
|Best Practices Guidelines - Asthma|
PRESTIGIOUS ASTHMA SOCIETIES SUPPORT FeNO MEASUREMENT
As the leader in the measurement of fractional exhaled nitric oxide (FeNO), Aerocrine is excited to announce that 2 prestigious asthma societies have formally endorsed FeNO measurement as a valuable tool for use in the assessment and management of asthma.
Last week, the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) released a joint position statement1 endorsing and supporting the American Thoracic Society’s (ATS) clinical practice guideline: Interpretation of Exhaled Nitric Oxide for Clinical Applications. The endorsement by the ACAAI and AAAAI underscores the importance of measuring FeNO to asses airway inflammation when determining appropriate treatment for patients with asthma.
The ATS guideline, which was published in September 2011, defines clinical situations in which FeNO testing is appropriate, as well as specific cut points to use when interpreting FeNO levels.2 The ATS guideline, now endorsed by the AAAAI and ACAAI, notes that FeNO testing provides valuable information to the physican that traditional clinical tools cannot provide.
We appreciate your support and will keep you updated on future news about FeNO measurement via monthly e-mails and communication with your local Aerocrine representatives.
Please contact us should you have any further questions regarding this communication
If a friend forwarded you this e-mail and you would like to receive future e-mails from Aerocrine, you may subscribe here.
References: 1. Zitt M, Oppenheimer J, Bernstein D, et al; on behalf of the ACAAI/AAAAI Joint Work Group. AAAAI/ACAAI joint statement of support of the ATS clinical practice guideline: Interpretation of Exhaled Nitric Oxide for Clinical Applications. http://www.acaai.org/Documents/FeNOJointStatement3-6-12.pdf. Published February 1, 2012. Accessed April 2, 2012. 2. Dweik RA, Boggs PB, Erzurum SC, et al: on behalf of the American Thoracic Society Subcommittee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602-615.
NIOX MINO®, NIOX®, and Aerocrine are registered trademarks of Aerocrine AB.
Asthma Action Plans
|Asthma Action Plan (Spanish)|
|ALA - Asthma||EPA - Asthma Resources||CDC - Asthma FAQs|
|Asthma Overview||Asthma Community Network||NHLBI - Asthma|
|NIH - Asthma||World Asthma Foundation||IN Joint Asthma Coalition|
|IN Dept of Environ Management||IKE Coalition||Happy Hollow Camp|
Durable Medical Equipment (DME's)
|Home Respiratory Services Inc||Knightingale Medical of Indiana LLC||At Home Health Equipment|
|8455 Castlewood DriveIndianapolis, IN 46250(317) 841-0202||5201 Park Emerson Drive Ste 6Indianapolis, IN 46203(317) 783-6123||4309 W 96th StIndianapolis, IN 46268(800) 848-4670www.ahhe.com|
|9019 Broken Arrow RoadIndianapolis, IN 46234(317) 271-7362||7353 Company DriveIndianapolis, IN 46237(317) 865-4200www.apria.com||4245 South Highschool RoadIndianapolis, IN 46241(317) 856-8841Lincare Disease Management|